List view / Grid view

Dr Jifeng Zhang (Research Professor at U-M Medical School)

 

news

Targeting inflammation to treat atherosclerosis and MASH

A glycine-based compound developed at the University of Michigan, originally…

5 May 2025 | By

A glycine-based compound developed at the University of Michigan, originally designed to treat severe fatty liver disease, has shown powerful effects in reducing atherosclerosis and vascular calcification in animal models.